SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-19-008553
Filing Date
2019-11-12
Accepted
2019-11-12 16:16:48
Documents
70
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT admp-10q_093019.htm 10-Q 1396314
2 FORM OF WARRANT DATED AUGUST 5, 2019 ex4-1.htm EX-4.1 132498
3 FORM OF STOCK APPRECIATION RIGHTS AGREEMENT FOR NON-EMPLOYEE DIRECTORS ex10-3.htm EX-10.3 76889
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 16669
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 16369
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 6402
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 6449
  Complete submission text file 0001387131-19-008553.txt   5669926

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT admp-20190930.xml EX-101.INS 1079760
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT admp-20190930.xsd EX-101.SCH 35987
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT admp-20190930_cal.xml EX-101.CAL 67110
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT admp-20190930_def.xml EX-101.DEF 201360
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT admp-20190930_lab.xml EX-101.LAB 340177
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT admp-20190930_pre.xml EX-101.PRE 294081
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36242 | Film No.: 191209646
SIC: 2834 Pharmaceutical Preparations